Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics, Inc. (RAPT) Cash from Operations (2020 - 2024)

RAPT Therapeutics' Cash from Operations history spans 5 years, with the latest figure at 10440000.0 for Q4 2024.

  • For Q4 2024, Cash from Operations rose 62.38% year-over-year to 10440000.0; the TTM value through Dec 2024 reached 83300000.0, up 14.17%, while the annual FY2024 figure was 83300000.0, 14.17% up from the prior year.
  • Cash from Operations for Q4 2024 was 10440000.0 at RAPT Therapeutics, up from 17622000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 6427000.0 in Q2 2020 and bottomed at 28808000.0 in Q2 2023.
  • The 5-year median for Cash from Operations is 16363500.0 (2022), against an average of 17631800.0.
  • The largest annual shift saw Cash from Operations crashed 116.52% in 2021 before it soared 62.38% in 2024.
  • A 5-year view of Cash from Operations shows it stood at 15366000.0 in 2020, then crashed by 34.59% to 20681000.0 in 2021, then dropped by 10.48% to 22849000.0 in 2022, then decreased by 21.47% to 27754000.0 in 2023, then skyrocketed by 62.38% to 10440000.0 in 2024.
  • Per Business Quant, the three most recent readings for RAPT's Cash from Operations are 10440000.0 (Q4 2024), 17622000.0 (Q3 2024), and 28154000.0 (Q2 2024).